https://www.fool.com/investing/general/2007/10/26/a-quarter-to-boast-about-at-bristol.aspx
https://www.fool.com/investing/high-growth/2007/08/14/a-surging-small-cap-in-canada.aspx
https://www.fool.com/investing/general/2007/06/19/a-healthy-bump-for-china-medical.aspx
https://www.fool.com/investing/value/2007/07/30/aetna-adds-to-its-bottom-line.aspx
https://www.fool.com/investing/high-growth/2007/09/24/getting-it-done-at-meridian-bioscience.aspx
https://www.fool.com/investing/high-growth/2007/10/19/keeping-pace-at-st-jude.aspx
https://www.fool.com/investing/high-growth/2007/08/24/narrowing-margins-at-new-york-company.aspx
https://www.fool.com/investing/high-growth/2007/06/27/improving-morale-at-barr.aspx
https://www.fool.com/investing/high-growth/2007/10/29/tarceva-sales-thrive-at-osi.aspx
https://www.fool.com/investing/general/2007/08/15/adversity-continues-for-avandia.aspx
https://www.fool.com/investing/general/2007/11/07/cardinal-has-its-wings-clipped.aspx
https://www.fool.com/investing/general/2007/10/08/wheeling-and-dealing-at-wyeth.aspx
https://www.fool.com/investing/high-growth/2007/07/25/dueling-fools-intuitive-surgical-bull.aspx
https://www.fool.com/investing/dividends-income/2007/08/08/housecleaning-at-prestige-brands.aspx
https://www.fool.com/investing/high-growth/2007/09/27/baxter-looking-to-bounce-back.aspx
https://www.fool.com/investing/dividends-income/2007/10/30/carolina-group-continues-to-roll-up-profits.aspx
https://www.fool.com/investing/general/2007/07/30/zoll-medical-still-on-a-roll.aspx
https://www.fool.com/investing/general/2007/07/20/sales-surge-at-intuitive-surgical.aspx
https://www.fool.com/investing/general/2007/10/09/the-full-flavored-quarter-of-yum-brands.aspx
https://www.fool.com/investing/high-growth/2007/10/25/dueling-fools-blue-nile-bull-rebuttal.aspx
https://www.fool.com/investing/general/2007/06/28/a-strong-start-for-big-health-care.aspx
https://www.fool.com/investing/small-cap/2007/11/21/dueling-fools-nuance-bull.aspx
https://www.fool.com/investing/dividends-income/2007/07/13/stimulating-sales-at-limited.aspx
https://www.fool.com/investing/general/2007/11/06/earnings-soar-uncertainty-looms-at-wellcare.aspx
https://www.fool.com/investing/small-cap/2007/09/06/a-cheap-gem.aspx
https://www.fool.com/investing/small-cap/2007/10/04/immucor-draws-first-blood.aspx
https://www.fool.com/investing/general/2007/10/08/mckesson-expands-its-empire.aspx
https://www.fool.com/investing/small-cap/2007/06/27/greeted-with-profits.aspx
https://www.fool.com/investing/international/2007/08/29/china-medical-continues-to-impress.aspx
https://www.fool.com/investing/high-growth/2007/10/30/are-the-ducks-all-in-a-row-for-forests-nebivolol.aspx
https://www.fool.com/investing/general/2007/06/29/timberland-gets-the-boot.aspx
https://www.fool.com/investing/general/2007/10/16/a-heartbreaker-at-medtronic.aspx
https://www.fool.com/investing/high-growth/2007/07/26/is-all-well-at-wellpoint.aspx
https://www.fool.com/investing/high-growth/2007/10/11/an-ipo-that-hit-the-bulls-eye.aspx
https://www.fool.com/investing/small-cap/2007/08/30/dueling-fools-ctripcom-bull-rebuttal.aspx
https://www.fool.com/investing/general/2007/09/19/prevnar-problems-at-wyeth.aspx
https://www.fool.com/investing/dividends-income/2007/10/05/dueling-fools-washington-mutual-bear.aspx
https://www.fool.com/investing/high-growth/2007/07/16/a-healthy-direction-for-wellcare.aspx
https://www.fool.com/investing/general/2007/08/09/resmed-rests-easy.aspx
https://www.fool.com/investing/high-growth/2007/10/25/dueling-fools-blue-nile-bull.aspx
https://www.fool.com/investing/small-cap/2007/08/17/no-love-for-estee-lauder.aspx
https://www.fool.com/investing/value/2007/11/05/still-fit-at-cigna.aspx
https://www.fool.com/investing/general/2007/07/20/wyeth-keeps-working-its-magic.aspx
https://www.fool.com/investing/general/2007/10/26/a-for-aetna.aspx
https://www.fool.com/investing/dividends-income/2007/07/19/altria-fights-back.aspx
https://www.fool.com/investing/general/2007/08/06/wellcare-continues-to-wow.aspx
https://www.fool.com/investing/general/2007/10/08/a-menace-to-big-pharma.aspx
https://www.fool.com/investing/value/2007/08/01/overseas-growth-sparks-osis-earnings.aspx
https://www.fool.com/investing/high-growth/2007/06/21/a-bull-run-at-bristol.aspx
https://www.fool.com/investing/general/2007/07/06/private-equity-turns-focus-to-nursing-homes.aspx
https://www.fool.com/investing/general/2007/08/06/molinas-q2-measures-up.aspx
https://www.fool.com/investing/general/2007/10/16/forest-labs-isnt-out-of-the-woods-yet.aspx
https://www.fool.com/investing/dividends-income/2007/09/05/lillys-pipeline-continues-to-produce.aspx
https://www.fool.com/investing/general/2007/11/02/successful-transitions-at-molina.aspx
https://www.fool.com/investing/general/2007/09/25/bristol-myers-buys-in-to-biologics.aspx
https://www.fool.com/investing/general/2007/10/08/5-stocks-choking-in-october.aspx
https://www.fool.com/investing/value/2007/11/06/5-health-care-stocks-bargain-or-bust.aspx
https://www.fool.com/investing/high-growth/2007/10/19/defying-intuition-at-intuitive-surgical.aspx
https://www.fool.com/investing/dividends-income/2007/10/12/dueling-fools-johnson-johnson-bear-rebuttal.aspx
https://www.fool.com/investing/high-growth/2007/07/06/medtronic-for-the-broken-hearted.aspx
https://www.fool.com/investing/high-growth/2007/10/30/5-top-health-care-and-biotech-stocks.aspx
https://www.fool.com/investing/general/2007/08/24/phillips-van-heusen-perseveres.aspx
https://www.fool.com/investing/general/2007/08/03/stormy-waters-at-wyeth.aspx
https://www.fool.com/investing/general/2007/10/25/wellpoint-well-on-its-way.aspx
https://www.fool.com/investing/general/2007/08/24/shoe-carnival-trips.aspx
https://www.fool.com/investing/general/2007/09/11/fda-takes-issue-with-boston-scientific.aspx
https://www.fool.com/investing/high-growth/2007/09/19/5-stocks-getting-a-boost-from-uncle-sam.aspx
https://www.fool.com/investing/small-cap/2007/11/21/dueling-fools-nuance-bull-rebuttal.aspx
https://www.fool.com/investing/general/2007/08/06/idexx-checks-out-in-good-health.aspx
https://www.fool.com/investing/dividends-income/2007/10/18/altria-lights-up.aspx
https://www.fool.com/investing/general/2007/10/02/closure-for-bristol-myers.aspx
https://www.fool.com/investing/small-cap/2007/09/21/robotics-momentum-continues.aspx
https://www.fool.com/investing/high-growth/2007/09/26/more-than-40-winks-from-arena.aspx
https://www.fool.com/investing/dividends-income/2007/10/12/johnson-johnson-bear.aspx
https://www.fool.com/investing/general/2007/10/26/things-get-ugly-at-wellcare.aspx
https://www.fool.com/investing/dividends-income/2007/10/05/dueling-fools-washington-mutual-bear-rebuttal.aspx
https://www.fool.com/investing/small-cap/2007/08/09/locked-in-to-geo-group.aspx
https://www.fool.com/investing/general/2007/10/19/wyeths-resilience.aspx
https://www.fool.com/investing/general/2007/09/07/epic-vioxx-victory-for-merck.aspx
https://www.fool.com/investing/small-cap/2007/08/31/glimmers-of-hope-at-zales.aspx
https://www.fool.com/investing/dividends-income/2007/10/18/an-empire-strykes-back.aspx
https://www.fool.com/investing/small-cap/2007/11/16/megagrowth-at-meridian-bioscience.aspx
https://www.fool.com/investing/general/2007/10/22/an-unwavering-approach-at-unitedhealth-group.aspx
https://www.fool.com/investing/high-growth/2007/11/07/surmodics-serves-up-a-big-quarter.aspx
https://www.fool.com/investing/high-growth/2007/10/18/still-sleepless-at-arena.aspx
https://www.fool.com/investing/high-growth/2007/10/04/on-target-at-northrop-grumm.aspx
https://www.fool.com/investing/general/2007/10/04/looking-to-keep-cholesterol-in-check-at-isis.aspx
https://www.fool.com/investing/dividends-income/2007/10/29/the-drag-on-reynolds-american.aspx
https://www.fool.com/investing/dividends-income/2007/08/30/altria-continues-its-breakup.aspx
https://www.fool.com/investing/high-growth/2007/07/25/dueling-fools-intuitive-surgical-bull-rebuttal.aspx
https://www.fool.com/investing/small-cap/2007/06/19/the-best-small-cap-for-2007-revisited.aspx
https://www.fool.com/investing/dividends-income/2007/07/27/reynolds-american-rises-above-the-ashes.aspx
https://www.fool.com/investing/small-cap/2007/09/24/a-fountain-of-youth.aspx
https://www.fool.com/investing/general/2007/10/08/vital-signs-at-medtronic.aspx
https://www.fool.com/investing/small-cap/2007/08/30/dueling-fools-ctripcom-bull.aspx
https://www.fool.com/investing/general/2007/10/10/monsantos-monster-year.aspx
https://www.fool.com/investing/dividends-income/2007/10/25/plenty-of-strength-in-zimmer.aspx
https://www.fool.com/investing/general/2007/09/20/more-options-for-healthy-bones.aspx
https://www.fool.com/investing/general/2007/10/25/cheesecake-factory-still-cooking.aspx
https://www.fool.com/investing/general/2007/07/20/unitedhealth-ultimately-unimpressive.aspx
